McCormick & Company Incorporated (MKC-V)vsNiagen Bioscience, Inc. (NAGE)
MKC-V
McCormick & Company Incorporated
$46.05
-3.60%
CONSUMER DEFENSIVE · Cap: $13.01B
NAGE
Niagen Bioscience, Inc.
$2.54
+1.60%
CONSUMER DEFENSIVE · Cap: $197.02M
Smart Verdict
WallStSmart Research — data-driven comparison
McCormick & Company Incorporated generates 5854% more annual revenue ($7.69B vs $129.08M). MKC-V leads profitability with a 19.4% profit margin vs 12.4%. MKC-V trades at a lower P/E of 8.4x. MKC-V earns a higher WallStSmart Score of 59/100 (C).
MKC-V
Buy59
out of 100
Grade: C
NAGE
Hold40
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+77.9%
Fair Value
$325.30
Current Price
$46.05
$279.25 discount
Intrinsic value data unavailable for NAGE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Every $100 of equity generates 21 in profit
Reasonable price relative to book value
17.4% revenue growth
Conservative balance sheet, low leverage
Every $100 of equity generates 23 in profit
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
Expensive relative to growth rate
Distress zone — elevated risk
Earnings declined 57.1%
Smaller company, higher risk/reward
Operating margin of 2.4%
Revenue declined 4.3%
Earnings declined 75.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : MKC-V
The strongest argument for MKC-V centers on P/E Ratio, Return on Equity, Price/Book. Profitability is solid with margins at 19.4% and operating margin at 17.8%. Revenue growth of 17.4% demonstrates continued momentum.
Bull Case : NAGE
The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.
Bear Case : MKC-V
The primary concerns for MKC-V are PEG Ratio, Altman Z-Score, EPS Growth.
Bear Case : NAGE
The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.
Key Dynamics to Monitor
MKC-V profiles as a growth stock while NAGE is a declining play — different risk/reward profiles.
NAGE carries more volatility with a beta of 2.02 — expect wider price swings.
MKC-V is growing revenue faster at 17.4% — sustainability is the question.
MKC-V generates stronger free cash flow (112M), providing more financial flexibility.
Bottom Line
MKC-V scores higher overall (59/100 vs 40/100), backed by strong 19.4% margins and 17.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
McCormick & Company Incorporated
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
McCormick & Company is an American multinational food company that manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavoring products to retail outlets, food manufacturers, and foodservice businesses.
Niagen Bioscience, Inc.
CONSUMER DEFENSIVE · PACKAGED FOODS · USA
Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.
Compare with Other PACKAGED FOODS Stocks
Want to dig deeper into these stocks?